Keyword Suggestion
Domain Informations
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 37.187.180.228
- Location: Paris France
- Latitude: 48.8543
- Longitude: 2.3527
- Timezone: Europe/Paris
Site Inspections
Port Scanner (IP: 37.187.180.228)
Spam Check (IP: 37.187.180.228)
Recent Searched Sites
› Ttbwa.com (19 seconds ago) / US
› Forum.uaewomen.net (20 seconds ago) / US
› Cosela.es (0 seconds ago) / FR
› Numbersixtyone.ie (1 mins ago) / US
› D68ydlh4zhpn2.cloudfront.net (11 seconds ago) / US
› Blog.byjus.com (39 seconds ago) / US
› Officesolutionpro.com (19 seconds ago) / US
› Esynthesis.in (48 seconds ago) / US
› Support.ku.ac.ke (11 seconds ago) / KE
› Turkanime.net (18 seconds ago) / US
› Nifonline.pt (41 seconds ago) / DK
› Gseb.org (2 mins ago) / IN
› Umn.x0.com (1 mins ago) / JP
› Annandaleatoms.net (33 seconds ago) / US
› Kiind.nl (18 seconds ago) / NL
› Oufc.co.uk (1 mins ago) / IE
› Phochaurochester.com (42 seconds ago) / US
› Eurofrance24.fr (3 seconds ago) / DE
› Jeffbelzerschevy.com (1 mins ago) / US
› Aiqfome.com (18 seconds ago) / US
Websites Listing
We found Websites Listing below when search with cosela.es on Search Engine
COSELA™ Overview | COSELA™ (trilaciclib) for injection ...
COSELA administration can cause injection-site reactions, including phlebitis and thrombophlebitis, which occurred in 56 (21%) of 272 patients receiving COSELA in clinical trials, including Grade 2 (10%) and Grade 3 (0.4%) adverse reactions. Monitor patients for signs and symptoms of injection-site reactions, including infusion-site pain and erythema during infusion. …
Cosela.comFDA Approves Cosela to Reduce Myelosuppression in ES-SCLC ...
2021-02-19 · Enter email addresses separated by commas if sending to more than one person. (200 characters max) Your Name: Your Email Address: Send me a copy. Personal Message: (Optional) These email addresses wil only be used to send out this message. Send. Close. Share. PRINT EMAIL FACEBOOK TWITTER LINKEDIN FEBRUARY 19, 2021. FDA …
Clinicaloncology.comCosela Approved To Treat Bone Marrow Suppression In …
2021-04-06 · Evidence for Cosela . Cosela was approved based on results from a clinical trial. Researchers studied 123 people on Cosela and a control group of 119 people who received a placebo (inactive pill) instead. All study participants had ES-SCLC and were being treated with chemotherapy. 5
Lungcancer.netNeutropenia Data | COSELA™ (trilaciclib) for injection ...
COSELA administration can cause injection-site reactions, including phlebitis and thrombophlebitis, which occurred in 56 (21%) of 272 patients receiving COSELA in clinical trials, including Grade 2 (10%) and Grade 3 (0.4%) adverse reactions. Monitor patients for signs and symptoms of injection-site reactions, including infusion-site pain and erythema during infusion. …
Cosela.comGmail
We would like to show you a description here but the site won’t allow us.
Mail.google.comCOSELA™ (trilaciclib) for injection, for IV use
COSELA administration can cause injection-site reactions, including phlebitis and thrombophlebitis, which occurred in 56 (21%) of 272 patients receiving COSELA in clinical trials, including Grade 2 (10%) and Grade 3 (0.4%) adverse reactions. Monitor patients for signs and symptoms of injection-site reactions, including infusion-site pain and erythema during infusion. …
Cosela.comDistributors - Ielab
COSELA, S.L. Distribution area: Andalucía and Extremadura Address: Polígono Parsi. c/ Parsi, 1. Nº 7, 41016 Sevilla, España; Telephone: 954 516 182 Email: cosela ...
Ielab.esFDA Approves G1 Therapeutics’ COSELA™ (trilaciclib): The
2021-02-13 · “COSELA will help change the chemotherapy experience for people who are battling ES-SCLC. G1 is proud to deliver COSELA to patients and their families as the first and only therapy to help ...
Globenewswire.comFDA Approves G1 Therapeutics’ COSELA™ (trilaciclib): The ...
2021-02-13 · “COSELA will help change the chemotherapy experience for people who are battling ES-SCLC. G1 is proud to deliver COSELA to patients and their families as the first and only therapy to help ...
Finance.yahoo.comCosela (Trilaciclib for Injection): Uses, Dosage, Side ...
2021-07-22 · Study 3: COSELA Prior To Topotecan Patients With ES-SCLC Previously Treated With Chemotherapy. Study 3 (G1T28-03; NCT02514447) was an international, randomized (2:1), double-blind, placebo-controlled study of COSELA or placebo administered prior to treatment with topotecan for patients with ES-SCLC previously treated with chemotherapy. The data …
Rxlist.comDilution COSELA (trilaciclib) for injection - GlobalRPH
2022-03-22 · COSELA (trilaciclib) for injection is a yellow lyophilized cake supplied in a single-dose vial. Each carton (NDC 73462-101-01) contains one 300 mg strength single-dose vial. Store COSELA vials at 20°C to 25°C (68°F to 77°F); excursions are permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
Globalrph.comG1 Therapeutics Provides First Quarter 2021 Financial ...
2021-05-05 · G1 will host a webcast and conference call at 4:30 p.m. ET today to provide a corporate and financial update for the first quarter 2021 ended March 31, 2021. The live call may be accessed by ...
Finance.yahoo.com2 free Magazines from COSELA.ES
2 Magazines from COSELA.ES found on Yumpu.com - Read for FREE
Yumpu.comCosela (trilaciclib) - CenterWatch
Study 2 (G1T28-02) was a randomized (1:1), double-blind, placebo-controlled evaluation of Cosela or placebo administered prior to treatment with etoposide and carboplatin (E/P) for patients with newly diagnosed ES-SCLC not previously treated with chemotherapy. A total of 77 patients were randomized to Cosela (n=39) or placebo (n=38) and stratified by ECOG …
Centerwatch.comNDC 73462-101 Cosela Trilaciclib - NDCList.com
Patients with newly diagnosed ES-SCLC not previously treated with chemotherapyStudy 2 (G1T28-02) was a randomized (1:1), double-blind, placebo-controlled evaluation of COSELA or placebo administered prior to treatment with etoposide and carboplatin (E/P) for patients with newly diagnosed ES-SCLC not previously treated with chemotherapy. A total of 77 patients …
Ndclist.comTrilaciclib - Wikipedia
Trilaciclib, sold under the brand name Cosela, is a medication used to reduce the frequency of chemotherapy-induced bone marrow suppression. The most common side effects include fatigue; low levels of calcium, potassium and phosphate; increased levels of an enzyme called aspartate aminotransferase; headache; and infection in the lungs (pneumonia). Trilaciclib may help …
En.wikipedia.org
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| nishnushnyc.com | tucows.com | -1 Years, -333 Days |
| expeditionsupply.com | ait.com | 211 Days |
| filthyoldies.com | danesconames.com | -1 Years, -318 Days |
| aresok.org | whois.godaddy.com | -2 Years, -67 Days |
| otvnepal.com | publicdomainregistry.com | -1 Years, -281 Days |
| cce.guru | wordpress.com | -1 Years, -154 Days |
| onlyclubbing.com | namecheap.com | -1 Years, -279 Days |
| bonuscasinosansdepot.net | godaddy.com | -2 Years, -32 Days |
| novel4up.com | namecheap.com | -2 Years, -231 Days |
| galerew.com | godaddy.com | 1 Year, 84 Days |